Xenetic Biosciences, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2012 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Xenetic Biosciences, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2012 to Q3 2024.
  • Xenetic Biosciences, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 1.54M shares, a 0.62% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 1.54M +9.54K +0.62% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 1.54M +8.5K +0.56% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 1.54M -13.6M -89.8% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 1.54M +24K +1.58% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 1.53M -12.8M -89.3% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 1.53M -12.8M -89.3% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 15.2M +1.73M +12.8% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 1.52M -11.9M -88.7% Dec 31, 2022 10-K 2024-03-21
Q3 2022 14.3M +931K +6.95% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 14.3M +5.57M +63.7% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 13.4M +4.69M +53.7% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 13.4M +4.69M +53.7% Dec 31, 2021 10-K 2023-03-22
Q3 2021 13.4M +7.09M +113% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 8.75M +2.45M +38.9% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 8.75M +2.46M +39.2% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 8.75M +2.68M +44.2% Dec 31, 2020 10-K 2022-03-22
Q3 2020 6.3M +663K +11.8% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 6.3M +5.37M +583% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 6.28M -4.16M -39.8% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 6.07M +5.28M +674% Dec 31, 2019 10-K 2021-03-16
Q3 2019 5.63M -3.77M -40.1% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 922K -8.48M -90.2% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 10.4M +1.73M +19.8% Mar 31, 2019 10-Q 2019-05-13
Q4 2018 784K -7.93M -91% Dec 31, 2018 10-Q 2019-11-14
Q3 2018 9.4M +686K +7.87% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 9.4M +686K +7.87% Jun 30, 2018 10-Q 2018-08-10
Q1 2018 8.72M +65K +0.75% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 8.72M +4.13M +90.1% Dec 31, 2017 10-K 2019-03-29
Q3 2017 8.72M +429K +5.18% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 8.72M -307K -3.41% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 8.65M -143M -94.3% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 4.59M 0 0% Dec 31, 2016 10-K 2018-03-30
Q3 2016 8.29M -142M -94.5% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 9.02M -130M -93.5% Jun 30, 2016 10-Q 2016-08-15
Q1 2016 152M +12.7M +9.12% Mar 31, 2016 10-Q 2016-05-16
Q4 2015 4.59M -135M -96.7% Dec 31, 2015 10-K 2017-03-31
Q3 2015 150M +13.9M +10.2% Sep 30, 2015 10-Q 2015-11-16
Q2 2015 139M +3.24M +2.39% Jun 30, 2015 10-Q 2015-08-19
Q1 2015 139M +3.24M +2.39% Mar 31, 2015 10-Q 2015-05-20
Q4 2014 139M +19.4M +16.2% Dec 31, 2014 10-K 2016-03-30
Q3 2014 136M Sep 30, 2014 10-Q 2014-11-14
Q2 2014 136M Jun 30, 2014 10-Q 2014-08-14
Q1 2014 136M Mar 31, 2014 10-Q 2014-05-20
Q4 2013 120M +55.4K +0.05% Dec 31, 2013 10-K/A 2015-07-20
Q4 2012 120M Dec 31, 2012 10-K/A 2015-07-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.